Target Price | $7.88 |
Price | $4.03 |
Potential |
95.41%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Corvus Pharmaceuticals, Inc. 2025 .
The average Corvus Pharmaceuticals, Inc. target price is $7.88.
This is
95.41%
register free of charge
$12.00
197.77%
register free of charge
$3.50
13.15%
register free of charge
|
|
A rating was issued by 4 analysts: 3 Analysts recommend Corvus Pharmaceuticals, Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Corvus Pharmaceuticals, Inc. stock has an average upside potential 2025 of
95.41%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.56 | -0.38 |
37.08% | 32.14% | |
P/E | negative |
2 Analysts have issued a Corvus Pharmaceuticals, Inc. forecast for earnings per share. The average Corvus Pharmaceuticals, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Corvus Pharmaceuticals, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.